Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Baker

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Frontline Gastroenterology|October 19, 2023
Young persons and healthcare professionals experience of virtual gastroenterology consultations: a multicentre survey conducted during the COVID-19 pandemicRhona Hubbard, Alenka Brooks, Naila Arebi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2025
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 TrialSarah Baker, Curtis Leclerc, Hanna Atmanspacher-Wirth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2023
Response to the letter-to-the-editor "Comments on: Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment"Gerda M Verduijn, Nienke D Sijtsema, Yvette van Norden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2023
Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatmentGerda M Verduijn, Nienke D Sijtsema, Yvette van Norden, et al.
Biomolecules|July 27, 2024
An Early Gestation Plasma Inflammasome in Rural Bangladeshi WomenHyunju Kim, Jacquelyn R Bedsaul-Fryer, Kerry J Schulze, et al.
Community Dentistry and Oral Epidemiology|June 19, 2026
Behaviour Support in Dentistry Core Outcomes (BeSiDe-CO): A Core Outcome Set Development StudyCaoimhin Mac Giolla Phadraig, Isabel C Olegário, Shaelynn Hsu, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2022
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinomaGerda M Verduijn, Steven F Petit, Iris Lauwers, et al.
Leukemia|October 16, 2019
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemiaBader Alanazi, Chinmay R Munje, Namrata Rastogi, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 21, 2021
Designing a Zn-Ag Catalyst Matrix and Electrolyzer System for CO<sub>2</sub> Conversion to CO and BeyondSarah Lamaison, David Wakerley, Frauke Kracke, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Frontline Gastroenterology|October 19, 2023
Young persons and healthcare professionals experience of virtual gastroenterology consultations: a multicentre survey conducted during the COVID-19 pandemicRhona Hubbard, Alenka Brooks, Naila Arebi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2025
The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 TrialSarah Baker, Curtis Leclerc, Hanna Atmanspacher-Wirth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 2023
Response to the letter-to-the-editor "Comments on: Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment"Gerda M Verduijn, Nienke D Sijtsema, Yvette van Norden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2023
Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatmentGerda M Verduijn, Nienke D Sijtsema, Yvette van Norden, et al.
Biomolecules|July 27, 2024
An Early Gestation Plasma Inflammasome in Rural Bangladeshi WomenHyunju Kim, Jacquelyn R Bedsaul-Fryer, Kerry J Schulze, et al.
Community Dentistry and Oral Epidemiology|June 19, 2026
Behaviour Support in Dentistry Core Outcomes (BeSiDe-CO): A Core Outcome Set Development StudyCaoimhin Mac Giolla Phadraig, Isabel C Olegário, Shaelynn Hsu, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2022
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinomaGerda M Verduijn, Steven F Petit, Iris Lauwers, et al.
Leukemia|October 16, 2019
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemiaBader Alanazi, Chinmay R Munje, Namrata Rastogi, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 21, 2021
Designing a Zn-Ag Catalyst Matrix and Electrolyzer System for CO<sub>2</sub> Conversion to CO and BeyondSarah Lamaison, David Wakerley, Frauke Kracke, et al.
Pageof 13